Skip to main content

Table 2 Demographic and clinical data of diabetic subjects with and without MACE

From: Sortilin levels correlate with major cardiovascular events of diabetic patients with peripheral artery disease following revascularization: a prospective study

 

NO MACE (n = 147)

MACE (n = 83)

p value

Age, years

71.17

71.11

0.961

Men:women, n

78.69

64:19

0

Body Mass Index, kg/m2

26.39

26.41

0.923

Diabetes duration, years

10.49

10.17

0.363

Ankle Brachial Index

0.72

0.47

0

High blood pressure, n (%)

94 (63.9)

71 (85.5)

0

Hypercholesterolemia, n (%)

84 (57.1)

65 (78.3)

0.001

CAD, n (%)

70 (47.6)

35 (42.2)

0.425

CVD, n (%)

80 (54.4)

44 (53.0)

0.837

Current smokers, n (%)

40 (27.2)

37 (44.6)

0.007

Past smokers, n (%)

46 (31.3)

44 (53.0)

0.001

Never smoked, n (%)

61 (41.5)

2 (2.4)

0

Rutherford 4, n (%)

96 (65.3)

10 (12.0)

0

Rutherford 5, n (%)

51 (34.7)

73 (88.0)

0

Total cholesterol, mg/dL

182.92

207.52

0

LDL cholesterol, mg/dL

103.55

130.33

0

Triglycerides, mg/dL

181.48

180.51

0.797

Glucose, mg/dL

120.12

121.59

0.405

HbA1C, %

8.93

8.71

0.423

eGFR mL/min/1.73 m2

71.36

70.60

0.669

Sortilin ng/mL

1.55

2.45

0

  1. BMI Body Mass Index, CAD Coronary Artery Disease, CVD Cerebrovascular Disease, LDL low-density lipoprotein, eGFR estimated glomerular filtration rate. Statistical test performed with Student’s t-test or with Chi square test, when appropriate